ISee3D Enters Agreement to Commercialize 3D in Advanced Laser Imaging Systems
30 Giugno 2010 - 9:09PM
Marketwired
ISee3D Inc. (TSX VENTURE: ICT) announced today that it has entered
into a license agreement with Hamilton Thorne Ltd., a leading
provider of advanced laser systems and instruments for in-vitro
cell applications.
Hamilton Thorne will combine commercial microscopes with their
advanced laser imaging systems, utilizing ISee3D's patented
single-lens single camera 3D technology, for stem cell regenerative
medicine and fertility clinic markets worldwide. ISee3D and
Hamilton Thorne are collaborating on prototype development with one
of the world's leading lens and microscope designers and
manufacturers, with the objective of having a commercial product
ready for sale in 2011.
"This agreement with Hamilton Thorne lays out a clear
commercialization path for microscopes empowered with our
single-lens single camera 3D technology," said ISee3D CEO Dwight
Romanica. "We look forward to working with Hamilton Thorne, and our
design and manufacturing partner, on development of both a
prototype and a leading commercially ready single-lens single
camera 3D microscope."
"Our research customers have long sought a simple and cost
effective method to incorporate true 3D images into their laser
applications," says Meg Spencer, Hamilton Thorne CEO. "I believe
that the extraordinary quality of the image in the ISee3D
technology will represent a major advantage to researchers in the
IVF and stem cell fields."
Under the terms of the agreement, ISee3D has granted Hamilton
Thorne exclusive worldwide rights, for a three-year period, to
commercialize a product, incorporating ISee3D's single-lens 3D
technology in their laser imaging systems used in stem cell
regenerative medicine and fertility clinic markets worldwide.
Hamilton Thorne has agreed to pay ISee3D a one-time license fee of
$150,000.00 USD, in addition to a royalty on each unit sold. Under
the agreement, ISee3D is also guaranteed a minimum annual
royalty.
About ISee3D Inc.
ISee3D Inc. (TSX VENTURE: ICT) owns certain patented technology
which provides for the capture of stereoscopic (3D) images through
a single lens. The Company's technology has broad applications in a
variety of markets including the home entertainment industry, and
consumer electronics, as well as industrial and imaging devices of
all types including microscopes, endoscopes as well as more
sophisticated medical imaging systems.
Statements included in this announcement, including statements
concerning our plans, intentions and expectations, which are not
historical in nature are intended to be, and are hereby identified
as, "forward-looking statements" for purposes of the safe harbor
provided by Section 21E of the Securities Exchange Act of 1934, as
amended by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may be identified by words including
"anticipates", "believes", "intends", "estimates", "expects" and
similar expressions. The company cautions readers that
forward-looking statements, including without limitation those
relating to the company's future operations and business prospects,
are subject to certain risks and uncertainties that could cause
actual results to differ materially from those indicated in the
forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: ISee3D Inc. Mr. Dwight Romanica (416) 848-6353
dromanica@isee3d.com www.isee3d.com
Grafico Azioni Isee3D Inc. (TSXV:ICT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Isee3D Inc. (TSXV:ICT)
Storico
Da Giu 2023 a Giu 2024